The store will not work correctly when cookies are disabled.
(Z)-9-(4-Ammoniumhydrochloride-2-butyl)-6-pyrrolylpurine
ID: ALA2261791
PubChem CID: 76323022
Max Phase: Preclinical
Molecular Formula: C13H17ClN6
Molecular Weight: 256.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cl.NCCCCn1cnc2c(-n3cccc3)ncnc21
Standard InChI: InChI=1S/C13H16N6.ClH/c14-5-1-2-8-19-10-17-11-12(15-9-16-13(11)19)18-6-3-4-7-18;/h3-4,6-7,9-10H,1-2,5,8,14H2;1H
Standard InChI Key: FPAXOSVZDBRDCT-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
18.5876 -8.4625 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.3124 -8.0687 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7997 -8.7334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3124 -9.4023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5304 -9.1459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8170 -9.5584 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0994 -9.1459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0994 -8.3209 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8170 -7.9084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5304 -8.3209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8170 -7.0835 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5689 -10.1885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4841 -6.5987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2292 -5.8141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4041 -5.8141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1494 -6.5987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3760 -10.3592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9273 -9.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7345 -9.9161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2859 -9.3024 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
2 10 1 0
5 10 2 0
9 11 1 0
4 12 1 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
12 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 256.31 | Molecular Weight (Monoisotopic): 256.1436 | AlogP: 1.36 | #Rotatable Bonds: 5 |
Polar Surface Area: 74.55 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.20 | CX LogP: 1.26 | CX LogD: -1.34 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.70 | Np Likeness Score: -1.33 |
References
1. Wittine K, Benci K, Kraljevic Pavelic S, Pavelic K, Bratulic S, Hock K, Balzarini J, Mintas M. (2011) Synthesis, cytostatic and anti-viral activity evaluation of the novel acyclic nucleoside analogues containing a sterically constrained (Z)-4-amino-2-butenyl moiety, 20 (3): [10.1007/s00044-010-9318-1] |